Stockscreener 앱 받기
58.91
0.27%
-0.035
Guardant Health Inc 주식(GH)의 최신 뉴스
Guardant Health raises 2025 revenue outlook to $915M–$925M amid strong Shield adoption and oncology momentum - MSN
Is Guardant Health Inc. impacted by rising ratesCEO Change & Real-Time Stock Movement Alerts - thegnnews.com
Detecting price anomalies in Guardant Health Inc. with AI2025 Breakouts & Breakdowns & Intraday High Probability Alerts - Newser
Can machine learning forecast Guardant Health Inc. recovery2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Live market analysis of Guardant Health Inc.2025 Key Lessons & Low Risk High Win Rate Picks - Newser
Can Guardant Health Inc. hit a new high this monthSwing Trade & Fast Momentum Stock Entry Tips - Newser
Guardant Health Inc. Stock Approaches Key Moving Average2025 Bull vs Bear & Long Hold Capital Preservation Tips - metal.it
Will Guardant Health Inc. rebound enough to break evenJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
Can Guardant Health Inc. be recession proof2025 Stock Rankings & Verified Short-Term Trading Plans - thegnnews.com
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 01net
What’s the analyst consensus on Guardant Health Inc.July 2025 Review & Weekly Setup with ROI Potential - kangso.co.kr
Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 26% Higher - 富途牛牛
Guardant Health Hits 52-Week High on $210M Volume Ranking 463rd Amid Institutional BuySell Splits - AInvest
Guardant Health stock reaches 52-week high at 59.25 USD By Investing.com - Investing.com Nigeria
Guardant Health stock reaches 52-week high at 59.25 USD - Investing.com
Cathie Wood’s ARK buys Bullish stock, sells Shopify and Guardant Health - Investing.com India
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - TradingView
Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know | FinancialContent - FinancialContent
Guardant Health at Canaccord Conference: Strategic Growth Unveiled By Investing.com - Investing.com Canada
GH Q2 Deep Dive: Strong Volume Growth and Product Expansion Amid Profitability Challenges - Yahoo Finance
The 5 Most Interesting Analyst Questions From Guardant Health’s Q2 Earnings Call - Yahoo Finance
Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 - uk.finance.yahoo.com
Exact Sciences Teams Up With Freenome to Take on Guardant Health in Colorectal Cancer Screening - MedCity News
Weekly Market Update: Stocks Rise as Basic Materials and Tech Gain - Morningstar
Guardant Health Surges 7.62% on $250M Volume Despite 396th Market Activity Rank - AInvest
Guardant Health Surges 13% on 197% Volume Spike Ranks 269th in Market Activity - AInvest
Guardant Health stock hits 52-week high at 53.49 USD By Investing.com - Investing.com South Africa
Guardant Health stock hits 52-week high at 53.49 USD - Investing.com
Guardant Health Soars 17.2% on Q2 Earnings Beat - AInvest
Exact Sciences acquires rights to rival Freenome’s blood-based colon cancer test - statnews.com
Multi-Cancer Early Detection Market Set to Revolutionize Cancer Diagnosis by 2034 | Driven by Liquid Biopsy Innovations and AI Integration - PharmiWeb.com
The Oncology Institute, Inc. shares rise 3.94% intraday after American Cancer Society and Guardant Health partnership. - AInvest
American Cancer Society and Guardant Health Partner to Expand Cancer Screening Access and Advance Health Equity - Business Wire
Is It Too Late to Sell Guardant Health Inc.Intraday Trend Analysis for Fast Gains Released - beatles.ru
Why is Guardant Health Inc. stock attracting strong analyst attentionRobust financial gains - Jammu Links News
What drives Guardant Health Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What is the risk reward ratio of investing in Guardant Health Inc. stockExceptional market positioning - Jammu Links News
Should I hold or sell Guardant Health Inc. stock in 2025Maximize portfolio value with expert tips - Jammu Links News
What catalysts could drive Guardant Health Inc. stock higher in 2025Exceptional trading results - Jammu Links News
How volatile is Guardant Health Inc. stock compared to the marketHarness the power of proven investment plans - Jammu Links News
What institutional investors are buying Guardant Health Inc. stockSignificant capital appreciation - Jammu Links News
Does Guardant Health Inc. stock perform well during market downturnsUnlock powerful portfolio management tools - Jammu Links News
What is Guardant Health Inc. company’s growth strategyMarket-leading growth rates - Jammu Links News
Is Guardant Health Inc. a growth stock or a value stockRapid growth trajectories - Jammu Links News
What are Guardant Health Inc. company’s key revenue driversStrong return on assets - Jammu Links News
Is Guardant Health Inc. stock overvalued or undervaluedAchieve breakthrough performance with smart picks - Jammu Links News
How many analysts rate Guardant Health Inc. as a “Buy”Unlock powerful portfolio management tools - Jammu Links News
Guardant Health (GH) introduces IHC Solid Tumor Testing to its Portfolio - MSN
Guardant Health, Inc. (NASDAQ:GH) Q2 2025 Earnings Call Transcript - Insider Monkey
Guardant Health Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Guardant Health Reports Strong Q2 2025 Growth - The Globe and Mail
Guardant Health Beat Wall Street Expectations And Raised Its Outlook - Finimize
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference - Yahoo Finance
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings - Benzinga
0.88%
0.51%
자본화:
|
볼륨(24시간):